- Home
- About
- Team
- Today's Market
- Premium
- Research it
- Outlook
- Portfolio
- Mobile
- Trust Equitymaster
- Help
- Free Reports
MEMBER'S LOGINX
| Login Failure | ||||||||
|
||||||||
| Sign Up | Forgot Password? | ||||||||
- Home
- Research It
- Compare Company
- Indian - consumer products
- BATA INDIA - P&G HYGIENE
BATA INDIA vs P&G HYGIENE - Comparison Results
BATA INDIA 
Change
Bata is India's largest footwear retailer of India. It is a part of the Bata Shoe Organisation and was incorporated in the year 1931. The company also manufactures footwear and has a wide retail network of over 1200 stores across India. It sells over... More
P&G HYGIENE
P&G Hygiene and Healthcare (PGHH) is a 69% subsidiary of the FMCG major - P&G, US. The two-product company is dominating both segments backed by strong brands, namely 'Vicks' in the anti-cold segment and 'Whisper' in feminine care segment (40% market... More
Current Valuations
| BATA INDIA | P&G HYGIENE | BATA INDIA/ P&G HYGIENE |
|||
|---|---|---|---|---|---|
| P/E (TTM) | x | 47.0 | 73.4 | 64.1% | View Chart |
| P/BV | x | 7.4 | 56.9 | 12.9% | View Chart |
| Dividend Yield | % | 0.5 | 0.3 | 157.5% |
Financials
 BATA INDIA  P&G HYGIENE |
| EQUITY SHARE DATA | |||||
|---|---|---|---|---|---|
| BATA INDIA Mar-17 |
P&G HYGIENE Jun-17 |
BATA INDIA/ P&G HYGIENE |
5-Yr Chart Click to enlarge
|
||
| High | Rs | 614 | 8,165 | 7.5% | |
| Low | Rs | 400 | 6,165 | 6.5% | |
| Sales per share (Unadj.) | Rs | 192.5 | 714.8 | 26.9% | |
| Earnings per share (Unadj.) | Rs | 12.4 | 133.3 | 9.3% | |
| Cash flow per share (Unadj.) | Rs | 17.4 | 151.7 | 11.5% | |
| Dividends per share (Unadj.) | Rs | 3.50 | 27.00 | 13.0% | |
| Dividend yield (eoy) | % | 0.7 | 0.4 | 183.3% | |
| Book value per share (Unadj.) | Rs | 103.0 | 162.1 | 63.6% | |
| Shares outstanding (eoy) | m | 128.53 | 32.46 | 396.0% | |
| Bonus/Rights/Conversions | - | - | - | ||
| Price / Sales ratio | x | 2.6 | 10.0 | 26.3% | |
| Avg P/E ratio | x | 41.0 | 53.7 | 76.3% | |
| P/CF ratio (eoy) | x | 29.1 | 47.2 | 61.6% | |
| Price / Book Value ratio | x | 4.9 | 44.2 | 11.1% | |
| Dividend payout | % | 28.3 | 20.3 | 139.7% | |
| Avg Mkt Cap | Rs m | 65,139 | 232,576 | 28.0% | |
| No. of employees | `000 | 4.7 | 0.4 | 1,289.5% | |
| Total wages/salary | Rs m | 2,732 | 1,141 | 239.4% | |
| Avg. sales/employee | Rs Th | 5,300.5 | 64,099.4 | 8.3% | |
| Avg. wages/employee | Rs Th | 585.2 | 3,151.9 | 18.6% | |
| Avg. net profit/employee | Rs Th | 340.5 | 11,953.9 | 2.8% | |
| INCOME DATA | |||||
|---|---|---|---|---|---|
| Net Sales | Rs m | 24,743 | 23,204 | 106.6% | |
| Other income | Rs m | 460 | 773 | 59.5% | |
| Total revenues | Rs m | 25,203 | 23,977 | 105.1% | |
| Gross profit | Rs m | 2,786 | 6,646 | 41.9% | |
| Depreciation | Rs m | 650 | 597 | 108.9% | |
| Interest | Rs m | 40 | 104 | 38.7% | |
| Profit before tax | Rs m | 2,555 | 6,718 | 38.0% | |
| Minority Interest | Rs m | 0 | 0 | - | |
| Prior Period Items | Rs m | 0 | 0 | - | |
| Extraordinary Inc (Exp) | Rs m | -217 | 0 | - | |
| Tax | Rs m | 749 | 2,390 | 31.3% | |
| Profit after tax | Rs m | 1,589 | 4,327 | 36.7% | |
| Gross profit margin | % | 11.3 | 28.6 | 39.3% | |
| Effective tax rate | % | 29.3 | 35.6 | 82.4% | |
| Net profit margin | % | 6.4 | 18.6 | 34.4% | |
| BALANCE SHEET DATA | |||||
|---|---|---|---|---|---|
| Current assets | Rs m | 13,619 | 6,031 | 225.8% | |
| Current liabilities | Rs m | 4,948 | 6,298 | 78.6% | |
| Net working cap to sales | % | 35.0 | -1.2 | -3,045.5% | |
| Current ratio | x | 2.8 | 1.0 | 287.4% | |
| Inventory Days | Days | 105 | 28 | 377.5% | |
| Debtors Days | Days | 10 | 21 | 49.0% | |
| Net fixed assets | Rs m | 2,908 | 3,266 | 89.1% | |
| Share capital | Rs m | 643 | 325 | 198.0% | |
| "Free" reserves | Rs m | 12,601 | 4,937 | 255.2% | |
| Net worth | Rs m | 13,243 | 5,261 | 251.7% | |
| Long term debt | Rs m | 0 | 0 | - | |
| Total assets | Rs m | 19,231 | 11,601 | 165.8% | |
| Interest coverage | x | 64.4 | 65.5 | 98.4% | |
| Debt to equity ratio | x | 0 | 0 | - | |
| Sales to assets ratio | x | 1.3 | 2.0 | 64.3% | |
| Return on assets | % | 8.5 | 38.2 | 22.2% | |
| Return on equity | % | 12.0 | 82.2 | 14.6% | |
| Return on capital | % | 18.0 | 129.7 | 13.9% | |
| Exports to sales | % | 0 | 0 | - | |
| Imports to sales | % | 0 | 0 | - | |
| Exports (fob) | Rs m | NA | NA | - | |
| Imports (cif) | Rs m | NA | NA | - | |
| Fx inflow | Rs m | 365 | 50 | 732.1% | |
| Fx outflow | Rs m | 2,035 | 1,627 | 125.1% | |
| Net fx | Rs m | -1,669 | -1,577 | 105.9% | |
| CASH FLOW | |||||
|---|---|---|---|---|---|
| From Operations | Rs m | 2,565 | 4,453 | 57.6% | |
| From Investments | Rs m | -2,288 | 1,493 | -153.3% | |
| From Financial Activity | Rs m | -557 | -15,587 | 3.6% | |
| Net Cashflow | Rs m | -280 | -9,642 | 2.9% | |
Share Holding
| Indian Promoters | % | 0.0 | 1.9 | - | |
| Foreign collaborators | % | 53.0 | 68.7 | 77.1% | |
| Indian inst/Mut Fund | % | 9.8 | 12.3 | 79.7% | |
| FIIs | % | 20.1 | 2.4 | 837.5% | |
| ADR/GDR | % | 0.0 | 0.0 | - | |
| Free float | % | 17.1 | 14.7 | 116.3% | |
| Shareholders | 83,621 | 22,617 | 369.7% | ||
| Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare BATA INDIA With: JYOTHY LABS COLGATE BAJAJ CORP RELAXO FOOTWEARS HIND. UNILEVER
Compare BATA INDIA With: UNILEVER PLC. (UK) P&G (US) HYPERMARCAS (Brazil)
|
| |
Today's Market
Sensex Ends Day in Red; SBI Up 3.7%(Closing)
After opening the day in green, share markets in India witnessed volatile trading activity throughout the day and ended the day on a negative note.
Related Views on News
Marico: Earnings Hit by Lower Volumes and Firming Input Prices (Quarterly Results Update - Detailed)
Aug 9, 2017While GST implementation brought down volumes and profitability in the short run, Marico remains optimistic in the long run.
P&G: Strong Core Growth (Quarterly Results Update - Detailed)
Dec 9, 2016Procter & Gamble Hygiene and Health Care has announced the first quarter results of the financial year ended June 2017 (1QFY17). The company's sales rose by 12.5%YoY while net profit rose by 50.1% YoY during the quarter.
P&G: Strong Core Performance (Quarterly Results Update - Detailed)
Oct 5, 2016Procter & Gamble Hygiene and Health Care reported a 0.1% YoY growth in sales and a 2.2% YoY increase in net profits during the quarter ended June 2016.
Marico: Earnings Hit by Lower Volumes and Firming Input Prices (Quarterly Results Update - Detailed)
Aug 9, 2017While GST implementation brought down volumes and profitability in the short run, Marico remains optimistic in the long run.
Nestle India: Sales Traction From New Products (Quarterly Results Update - Detailed)
Nov 30, 2016Nestle India declared results for the quarter ended September 2016. Here is our analysis of the result.
More Views on NewsMost Popular
My Top Five Stocks After the Karnataka Elections(The 5 Minute Wrapup)
May 16, 2018The markets seem confused. They're neither going up nor down. What should investors do? Consider Safe Stocks. Here's the top 5 Safe Stocks in the market today.
How A Storm Destroyed Rain Industries... And a Superb Small Cap Stock I Recommend(Profit Hunter)
May 17, 2018A mutual fund regulation could cause small cap prices to tank - If you haven't been paying attention to your small caps - now is the time to catch the opportunities that start pouring in.
Has the Indian Home Buyer Become Smarter?(Vivek Kaul's Diary)
May 17, 2018Home loans continue to grow, despite falling sales. What explains this phenomenon?
Looking Beyond the Colourful Prism of This Airline Company(Sector Info)
May 10, 2018Can Interglobe Aviation Safely Fly Out of Turbulence?
Beware of Inflated Stock Market Angels(Sector Info)
May 17, 2018The stock of Vakrangee helps us understand why it's a bad idea to chase high-flying stocks.
More|
| |
BATA INDIA SHARE PRICE
May 23, 2018 (Close)
TRACK BATA INDIA
- Track your investment in BATA INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
- Add To MyStocks
MORE ON BATA INDIA
BATA INDIA - JYOTHY LABS COMPARISON
COMPARE BATA INDIA WITH
OTHER USEFUL LINKS
MARKET STATS
ABOUT EQUITYMASTER
Since 1996, Equitymaster has been the source for honest and credible opinions on investing in India. With solid research and in-depth analysis Equitymaster is dedicated towards making its readers- smarter, more confident and richer every day. Here's why hundreds of thousands of readers spread across more than 70 countries Trust Equitymaster.
FREE NEWSLETTERS
PREMIUM PRODUCTS
QUICK LINKS
APPS
FOLLOW
Copyright © Equitymaster Agora Research Private Limited.
Whitelist | Refer | Terms | Privacy | Contact | Advertise | About | Sitemap
Equitymaster Agora Research Private Limited. 103, Regent Chambers, Above Status Restaurant, Nariman Point, Mumbai - 400 021. India.
Telephone: +91-22-61434055. Fax: +91-22-22028550. Email: info@equitymaster.com. Website: www.equitymaster.com. CIN:U74999MH2007PTC175407
All rights reserved. Any act of copying, reproducing or distributing this newsletter whether wholly or in part, for any purpose without the permission of Equitymaster is strictly prohibited and shall be deemed to be copyright infringement.
LEGAL DISCLAIMER: Equitymaster Agora Research Private Limited (hereinafter referred as 'Equitymaster') is an independent equity research Company. Equitymaster is not an Investment Adviser. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and Equitymaster will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein. Information contained herein does not constitute investment advice or a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual subscribers. Before acting on any recommendation, subscribers should consider whether it is suitable for their particular circumstances and, if necessary, seek an independent professional advice. This is not directed for access or use by anyone in a country, especially, USA, Canada or the European Union countries, where such use or access is unlawful or which may subject Equitymaster or its affiliates to any registration or licensing requirement. All content and information is provided on an 'As Is' basis by Equitymaster. Information herein is believed to be reliable but Equitymaster does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. Equitymaster may hold shares in the company/ies discussed herein. As a condition to accessing Equitymaster content and website, you agree to our Terms and Conditions of Use, available here. The performance data quoted represents past performance and does not guarantee future results.
SEBI (Research Analysts) Regulations 2014, Registration No. INH000000537.